Vancomycin vs. nitazoxanide to treat Clostridium difficile colitis that has failed therapy with metronidazole

Trial Profile

Vancomycin vs. nitazoxanide to treat Clostridium difficile colitis that has failed therapy with metronidazole

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Jun 2015

At a glance

  • Drugs Nitazoxanide (Primary) ; Vancomycin (Primary)
  • Indications Clostridium infections; Colitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 29 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top